+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
BVL BVL

Blueblood Ventures Share Price

₹11.07 +0 (0%)

29 May, 2023 11:34 AM (IST)

Blueblood Ventures live price: ₹11.07. It opened at ₹11 vs previous close ₹11; intraday high/low: ₹11/₹11. The 50 DMA stands at ₹13.30.

Blueblood Ventures Performance

  • Today's Low
  • ₹11
  • Today's High
  • ₹11
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹11
  • Previous Close₹11
  • Volume15,000
  • 50 DMA₹13.30
  • 100 DMA₹24.90
  • 200 DMA-

Blueblood Ventures Chart

Investment Returns

Smart Investing Starts Here Start SIP with Blueblood Ventures for Steady Growth!

Invest Now

Blueblood Ventures Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 101.9
  • PEG Ratio
  • -
  • Market Cap Cr
  • 3
  • P/B Ratio
  • 1.1
  • Average True Range
  • 0.9
  • EPS
  • 0.1
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.2
  • RSI
  • 55.65
  • MFI
  • 84.69

Latest Stock News Updates

Blueblood Ventures Ltd - 539637 - General Announcement- The Board Of Directors Of Blueblood Ventures Limited (''''The Company''''), At Its Meeting Held Today, I.E., Friday, 09 October 2026, At The Registered Office Of The Company, Has Considered And Approved The Following Matters: 1. Appointment Of Internal Auditor M/S. Mahesh Sharma & Associates, Chartered Accountants (Firm Registration No. 014330N), As The Internal Auditor Of The Company For The Financial Years 2026-27 To 2030-31. 2. The Appointment Of Mr. Chandrashekhar Singh (DIN: 05131693) As An Additional Director In The Category Of Non-Executive Independent Director Of The Company With Effect From 09 October 2026.3.Opening Of Branch Office At Kolkata. 4. Approved The Debt Assignment Transaction.

The Board of Directors of Blueblood Verntures Limited("the Company") , at its meeting held today, i.e., Friday, 09 Octobeer 2026 at the registered office of the Company, has considered and approved the following matters: 1. Appointment of Internal Auditor 2. Appointment of Mr. Chandrashekhar Singh as an Additional Director 3. Opening of Branch Office at Kolkata 4. Approved the Debt Assignment Transaction. The Meeting Commenced at 3: 00 P.M. and concluded at 4: 20 P.M.

Blueblood Ventures Ltd - 539637 - Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (''Listing Regulations''), We Wish To Inform You That The Board Of Directors Of Blueblood Ventures Limited (''The Company''), At Its Meeting Held Today, I.E., Friday, 09 October 2026, At The Registered Office Of The Company, Has Considered And Approved The Following Matters: 1. Appointment Of Internal Auditor M/S. Mahesh Sharma & Associates, Chartered Accountants (Firm Registration No. 014330N), As The Internal Auditor Of The Company For The Financial Years 2026-27 To 2030-31. 2. The Appointment Of Mr. Chandrashekhar Singh (DIN: 05131693) As An Additional Director In The Category Of Non-Executive Independent Director Of The Company With Effect From 09 October 2026.3.Opening Of Branch Office At Kolkata. 4. Approved The Debt Assignment Transaction.

The Board of Directors of Blueblood Ventures Limited("the company"), at its meeting held today i.e., Friday, 09 October 2026, at the registered office of the Company, has considered and approved the following matters: 1. Appointment of Internal Auditor 2. Appointment of Mr. Chandrashekhar Singh as an Additional Director 3. Opening of branch office at Kolkata 4. Approval of Debt Assignment Transaction. The meeting Commenced at 3:00 P.M. to 4: 20 P.M.

Blueblood Ventures Ltd - 539637 - Board Meeting Outcome for Outcome Of Board Meeting Held On 09 October 2026.

Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (''Listing Regulations''), We Wish To Inform You That The Board Of Directors Of Blueblood Ventures Limited (''The Company''), At Its Meeting Held Today, I.E., Friday, 09 October 2026, At The Registered Office Of The Company, Has Considered And Approved The Following Matters: 1. Appointment Of Internal Auditor M/S. Mahesh Sharma & Associates, Chartered Accountants (Firm Registration No. 014330N), As The Internal Auditor Of The Company For The Financial Years 2026-27 To 2030-31. 2. The Appointment Of Mr. Chandrashekhar Singh (DIN: 05131693) As An Additional Director In The Category Of Non-Executive Independent Director Of The Company With Effect From 09 October 2026.3.Opening Of Branch Office At Kolkata. 4. Approved the Debt Assignment Transaction.

Blueblood Ventures Financials

Blueblood Ventures Technicals

EMA & SMA

Current Price
₹11.07
0 (0%)
pointer
  • Bearish Moving Average 3
  • Bullish Moving Average 10
  • 20 Day
  • ₹9.60
  • 50 Day
  • ₹13.30
  • 100 Day
  • ₹24.90
  • 200 Day
  • -

Resistance and Support

11.09 Pivot Speed
  • R3 11.10
  • R2 11.10
  • R1 11.10
  • S1 11.10
  • S2 11.10
  • S3 11.10

Blueblood Ventures Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-10-09 Others
2026-05-27 Audited Results
2025-11-14 Half Yearly Results
2025-05-29 Audited Results
2024-11-14 Half Yearly Results

Blueblood Ventures Shareholding Pattern

53.12%
46.89%
0%

About Blueblood Ventures

Blueblood Ventures is engaged in the business of equity investment and trading in equity, derivatives, commodities, futures, and options, as well as other financialproducts. View More
  • NSE Symbol
  • BVL
  • BSE Symbol
  • 539637
  • Executive Director,Managing Director,Chief Financial Officer
  • Suresh Bohra
  • ISIN
  • INE562S01013

Similar Stocks to Blueblood Ventures

Blueblood Ventures FAQs

Blueblood Ventures share price is ₹11 As on 22 October, 2026 | 09:26

The Market Cap of Blueblood Ventures is ₹3.3 Cr As on 22 October, 2026 | 09:26

The P/E ratio of Blueblood Ventures is 101.9 As on 22 October, 2026 | 09:26

The PB ratio of Blueblood Ventures is 1.1 As on 22 October, 2026 | 09:26

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23